Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology-Reference-Cited by-同舟云学术

Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology

Published:2023-09 Issue:5 Volume:43 Page:622-635
ISSN:2013-2514
Container-title:Nefrología (English Edition)
language:en
Short-container-title:Nefrología (English Edition)

Author:

Alonso Fabiola,Martín de Francisco Ángel L.M.,Auñón Pilar,García-Carro Clara,García Patricia,Gutiérrez Eduardo,Mcía Manuel,Quintana Luis F.,Quiroga Borja,Soler María José,Torregrosa Isidro

Publisher

Elsevier BV

Subject

Nephrology

Reference50 articles.

1. Grupo español de Onconefrología, Sociedad Española de Nefrología. https://www.senefro.org/modules.php?name=workgroups&op=detail&workgroup_id=13.

2. Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations;Hoos;Nat Rev Drug Discov,2016

3. The evolutionary legacy of immune checkpoint inhibitors;Kaushik;Semin Cancer Biol,2022

4. Immunotherapy Through the Years;Eno;J Adv Pract Oncol,2017

5. Immune Checkpoint. Inhibitor Nephrotoxicity: Update 2020;Gupta;Kidney360,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disseminate Cutaneous Vasculitis Associated with Durvalumab Treatment—Case Report, Mini-Review on Cutaneous Side Effects of Immune Checkpoint Inhibitor Therapies with Machine Learning Perspectives;Life;2024-08-25

2. Immune checkpoint inhibitor–associated nephritis—treatment standard;Nephrology Dialysis Transplantation;2024-08-13

3. Renal Adverse Reaction Secondary to Check-point Inhibitors in Metastatic Renal Cancer;Journal of Clinical Nephrology;2024-05-17

4. Management Update in Immunotherapy and Kidney Injury;Interdisciplinary Cancer Research;2024